Fundz

Eliaz Therapeutics reported raising $850,000 in an initial SEC Form D filing, from an offering of $850,000

PRIVATEOct 24, 2025Late filing, first sale Mar 28, 2025

Amount Raised

$850,000

$850,000 sold, per SEC Form D (first sale Mar 28, 2025)

Round Type

Seed

Santa RosaHealthcaremedical devices

Quick answer

Eliaz Therapeutics raised $850,000 in a Seed round, dated March 28, 2025. Eliaz Therapeutics is based in Santa Rosa, California, United States.

How much did Eliaz Therapeutics raise?
Eliaz Therapeutics raised $850,000 in a Seed round on March 28, 2025.
What does Eliaz Therapeutics do?
Eliaz Therapeutics Inc is a biotechnology and MedTech company founded in 2015 by Dr. Isaac Eliaz, specializing in innovative therapeutic apheresis devices.
Where is Eliaz Therapeutics based and how big is it?
Eliaz Therapeutics is based in Santa Rosa, California, United States. Fundz records about 8 employees.
Who are the decision-makers at Eliaz Therapeutics?
Fundz holds 1 contact at Eliaz Therapeutics, including the CEO & Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and medical devices around the same time

Companies in the same sectors as Eliaz Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $20M (Series B) on February 21, 2025.
  • Hummingbird Healthcare raised $19M on February 14, 2025.
  • Rimidi raised $800K (Seed) on May 9, 2025.
  • MetaVia raised $10M on May 8, 2025.
  • ZignaAI raised $90M on May 7, 2025.
  • Zyus raised $574K (Seed) on May 6, 2025.

Who to call at Eliaz Therapeutics, and when

A new round usually means Eliaz Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eliaz Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eliaz Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eliaz Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eliaz Therapeutics

Location

398 Tesconi Court

Santa Rosa, California, United States

About

Eliaz Therapeutics Inc is a biotechnology and MedTech company founded in 2015 by Dr. Isaac Eliaz, specializing in innovative therapeutic apheresis devices. The company focuses on developing technology to selectively remove Galectin-3 (Gal-3) from the bloodstream, a protein linked to severe inflammatory and fibrotic diseases, immune dysregulation, kidney deterioration, and cancer. The flagship product, the XGal-3® apheresis column, is an FDA Breakthrough Device designed to treat sepsis and sepsis-induced acute kidney injury (AKI). This device aims to improve patient outcomes by targeting Galectin-3, addressing conditions that currently lack effective treatments. Eliaz Therapeutics holds over 60 patents worldwide and has received NIH funding for research and development. The company is supported by global manufacturing partnerships and a leadership team with extensive experience in healthcare and biotech, targeting hospitals and healthcare providers managing critical care patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eliaz Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsIsaac, CEO & Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Eliaz Therapeutics's next move

See what Strategic adds

Eliaz Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.